Mechanisms and consequences of epithelial cell survival from influenza virus infection.
Mechanisms and consequences of epithelial cell survival from influenza virus infection.
批准号:
10177849
负责人:
Ryan Langlois
金额:
$38.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-06-01 至 2023-05-31
关键词:
AcuteAddressAffectAnatomyAntibodiesAntigensAntiviral AgentsCD8-Positive T-LymphocytesCell SurvivalCellsComplexDataEnterobacteria phage P1 Cre recombinaseEpithelialEpithelial CellsEquilibriumFailureFlow CytometryFluorescence MicroscopyGenesGoalsImmuneImmune responseImmune systemIndividualInfectionInfluenza A virusInfluenza Virus Infected CellsInterferonsKnowledgeLabelLeadLigandsLocationLungLung infectionsMHC antigenMapsMeasuresMediatingMediator of activation proteinMolecularMorbidity - disease rateMusPathologyPhasePhenotypePositioning AttributePulmonary PathologyRecoveryReporterResearchResistanceRespiratory SystemRoleSurfaceSystemTestingTropismViral AntigensViral GenomeViral ProteinsVirusVirus DiseasesVirus Replicationacute infectionadaptive immune responsealveolar type II cellantiviral immunitycell killingcell typedifferential expressiondiphtheria toxin receptorexperiencefluorophoregenetic signatureimmune clearanceimmunoregulationin vivoinfluenza infectioninfluenzaviruslung repairlytic replicationmortalitynovel viruspandemic diseasepathogenpreferencepreventprogrammed cell death protein 1receptorrepairedresponsetoolvirus host interaction
中文摘要
项目摘要
流感病毒每年在全世界引起显著的发病率和死亡率。该病毒具有广泛的嗜性,
呼吸道的上皮细胞为了清除感染,免疫系统必须对抗这些不同的
可以携带不同水平的病毒或病毒抗原:MHC的细胞具有不同的表达,
抑制性配体,并存在于不同的解剖位置。确定病毒感染者的长期命运
细胞,我们开发了一种新的病毒,能够永久标记报告小鼠中的感染细胞。通过插入
Cre重组酶导入病毒基因组,感染小鼠可永久表达Cre诱导荧光团
标记细胞,并允许长期跟踪和研究受感染的细胞。利用这个工具,我们制作了
令人惊讶的发现是,并非所有先前感染的细胞都被裂解性病毒复制或适应性病毒复制杀死。
免疫反应我们假设CD8 T细胞杀死或赦免受感染的上皮细胞,这取决于细胞
类型、细胞内病毒复制的状态和病毒诱导的抑制性配体表达。我们进一步
假设存活的细胞是肺恢复的关键介质。因为我们可以看到细胞
在感染的整个清除阶段,我们可以利用这个系统来研究上皮细胞,
被CD8 T细胞杀死以及允许感染的机制。本提案的目标是:1)确定
感染细胞逃避CD8 T细胞介导的杀伤的机制2)定义存活细胞的作用
3)绘制被CD8 T细胞清除的感染细胞图,4)阐明
在抗病毒免疫反应面前保护和允许新细胞感染的机制。
重要的是,在这些研究中采用的不可磨灭的标记系统可以扩展到IAV以外的任何
能够接受外来基因插入的病毒。该提案的结果将揭示基本的
抗病毒免疫、细胞抗性和存活以及肺部恢复的机制。
英文摘要
Project Summary
Influenza virus causes significant morbidity and mortality worldwide annually. The virus has a broad tropism for
epithelial cells in the respiratory tract. To clear the infection the immune system must confront these diverse
cells which can be harboring different levels of virus or virus antigen:MHC, have differential expression of
inhibitory ligands, and reside in different anatomical locations. To determine the long-term fate of virus infected
cells we developed a novel virus capable of permanent labeling of infected cells in reporter mice. By inserting
Cre recombinase into the virus genome, infection of mice expressing a Cre-inducible fluorophore permanently
labels the cells and allows for long-term tracking and study of infected cells. Using this tool we made the
surprising discovery that not all previously infected cells are killed by the lytic virus replication or the adaptive
immune response. We hypothesize that CD8 T cells kill or pardon infected epithelial cells depending on cell
type, the state of virus replication within the cell, and virus-induced expression of inhibitory ligands. We further
hypothesize that surviving cells are critical mediators of pulmonary recovery. Because we can visualize cells
throughout the clearance phase of infection we can exploit this system to study the epithelial cells that are
killed by CD8 T cells and the mechanisms that permit infection. The goals of this proposal are to: 1) Determine
the mechanisms of infected cell evasion from CD8 T cell-mediated killing 2) Define the roles of surviving cells
in pulmonary repair and recovery 3) Map the infected cells that are eliminated by CD8 T cells and 4) Elucidate
the mechanisms that protect and permit infection of new cells in the face of antiviral immune responses.
Importantly, the indelible labeling system employed during these studies can be extended beyond IAV, to any
virus that is amenable to foreign gene insertions. Results from this proposal will uncover fundamental
mechanisms in antiviral immunity, cellular resistance and survival, and pulmonary recovery.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.chom.2021.10.001
发表时间:
2021-12-08
期刊:
Cell host & microbe
影响因子:
30.3
作者:
[Fiege JK, Block KE, Pierson MJ, Nanda H, Shepherd FK, Mickelson CK, Stolley JM, Matchett WE, Wijeyesinghe S, Meyerholz DK, Vezys V, Shen SS, Hamilton SE, Masopust D, Langlois RA]
通讯作者:
Langlois RA
Natural model for evaluating within- and cross-species virus transmission
-
批准号:10735974
-
项目类别:
-
资助金额:$73.92万
-
财政年份:2023
-
负责人:Ryan Langlois
-
依托单位:
Core E: Cellular and Organismic Systems for Antiviral Testing
-
批准号:10522809
-
项目类别:
-
资助金额:$845.18万
-
财政年份:2022
-
负责人:Ryan Langlois
-
依托单位:
New mouse model to better predict human immunity to influenza vaccination and infection
-
批准号:10460340
-
项目类别:
-
资助金额:$61.53万
-
财政年份:2021
-
负责人:Ryan Langlois
-
依托单位:
New mouse model to better predict human immunity to influenza vaccination and infection
-
批准号:10663220
-
项目类别:
-
资助金额:$61.53万
-
财政年份:2021
-
负责人:Ryan Langlois
-
依托单位:
New mouse model to better predict human immunity to influenza vaccination and infection
-
批准号:10188769
-
项目类别:
-
资助金额:$61.53万
-
财政年份:2021
-
负责人:Ryan Langlois
-
依托单位:
Early Responses to Influenza A Virus Replication In Vivo
-
批准号:10579883
-
项目类别:
-
资助金额:$50.13万
-
财政年份:2020
-
负责人:Ryan Langlois
-
依托单位:
Early Responses to Influenza A Virus Replication In Vivo
-
批准号:10353410
-
项目类别:
-
资助金额:$50.13万
-
财政年份:2020
-
负责人:Ryan Langlois
-
依托单位:
Harnessing microRNAs to explore influenza virus immunity
-
批准号:8821743
-
项目类别:
-
资助金额:$16.2万
-
财政年份:2015
-
负责人:Ryan Langlois
-
依托单位:
海外基金